Pharmacology Consult

Pharmacology Consult

A closer look at drug discoveries and developments that affect clinical practice.

Pharmacology Consult

The good, bad and unnecessary prescribing of oral vancomycin prophylaxis in immunosuppressed patients

Infectious Disease News, June 2019
Jennifer Ross, PharmD; Kimberly D. Boeser, PharmD, MPH, BCIDP
Clostridioides difficile infection, or CDI, continues to be a significant pathogen in both hospitals and community-based settings. The associated…
Pharmacology Consult

Risk-based approach must guide VTE prophylaxis for ambulatory patients with cancer

HemOnc Today, February 25, 2019
Jai N. Patel, PharmD, BCOP
Individuals with cancer are more than four times as likely as those in the general population to develop venous thromboembolism. Chemotherapy receipt…
Pharmacology Consult

Urgent action necessary to address opioid drug shortage

HemOnc Today, August 25, 2018
Jai N. Patel, PharmD, BCOP
The frequency of drug shortages in the United States is rapidly increasing. Shortages of opioid drugs — such as injectable hydromorphone…
Pharmacology Consult

Summertime fun and dangers

Infectious Diseases in Children, July 2018
Edward A Bell, PharmD, BCPS
Summer is officially here, children are out of school, and summertime outdoor fun is beginning. Unfortunately, potential dangers are beginning as…
Pharmacology Consult

Preventing meningococcal disease in patients receiving Soliris

Infectious Disease News, May 2018
Leah Molloy, PharmD
Soliris is a humanized monoclonal antibody that has emerged as a life-saving therapy for certain rare diseases but carries with it the risk for…
Pharmacology Consult

Effective pharmacological management of depression ‘imperative’ for patients with cancer

HemOnc Today, June 25, 2017
Jai N. Patel, PharmD, BCOP
Major depression is a significant comorbidity in cancer, with prevalence estimated at 15% to 20%. Depression has been associated with prolonged…
Pharmacology Consult

Personalized approach must guide extended aromatase inhibitor therapy for breast cancer

HemOnc Today, February 25, 2017
Jai N. Patel, PharmD
Approximately 75% of patients with breast cancer have hormone receptor–positive disease, in which growth and replication depends on estrogen…
Pharmacology Consult

Ability to harness immune system may provide urgently needed therapies for pancreatic cancer

HemOnc Today, December 10, 2016
Jai N. Patel, PharmD
In contrast to the steady increase in survival for most cancers, advances have been slow for pancreatic cancers. Five-year relative survival is less…
Pharmacology Consult

Management of chemotherapy-induced peripheral neuropathy requires personalized approach

HemOnc Today, May 25, 2016
Jai N. Patel, PharmD
Chemotherapy-induced peripheral neuropathy is a frequent and debilitating adverse effect of commonly used chemotherapy agents. These agents include…
Pharmacology ConsultPublication Exclusive

Biosimilars may expand drug access, reduce costs, but still much to learn

HemOnc Today, February 10, 2016
Jai N. Patel, PharmD
Cancer is the major indication for six of the 10 best-selling biological products. Meanwhile, the cost of cancer biologics in the United States has…